Treatment strategies for patients with HER2-positive gastric cancer
Feixue Wang, Yi Ba
Abstract
Gastric cancer (GC) is a major health concern globally, ranking fifth in frequency and fourth in cancer-associated mortality[1][1]. In China, an estimated 396,500 new cases are diagnosed each year, and late-stage disease comprises more than 80% of cases[2][2]. Because of late diagnosis and
Topics & Concepts
CancerMedicineInternal medicineStage (stratigraphy)DiseaseGastroenterologyOncologyPaleontologyBiologyGastric Cancer Management and OutcomesHelicobacter pylori-related gastroenterology studiesHER2/EGFR in Cancer Research